Skip to content

Clinical trials

Severe Acute Respiratory Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20181
20201
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
AstraZeneca1
BioNTech SE1
Hospital Authority, Hong Kong1
Huashan Hospital1
National Taiwan University Hospital1
Peking University People's Hospital1
Yang I. Pachankis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome9
Coronavirus Infections3
COVID-192
Respiratory Tract Infections2
Virus Diseases2
Infections1
Influenza, Human1
Lung Diseases1
Respiratory Distress Syndrome1

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.